Becker's Healthcare July 10, 2024
A Boston-based Harvard Medical School study found oncologists unsure how to handle artificial intelligence if it presents a treatment plan they would not recommend.
The study, published in March in JAMA Network Open, surveyed 204 oncologists between Nov. 15, 2022, and July 31, 2023. Of participants, 84.8% said AI-based clinical decision models needed to be explainable by oncologists but did not need to be explained to patients; and 81.4% said patients should consent to the use of AI to support treatment decisions.
However, the study also found that if AI selected a treatment regimen different from what an oncologist would recommend, 36.8% said they would present both options and let the patient decide. This was the most common response among...
Today's Sponsors
Today's Sponsor